Lung cancer, Secondary cancers, Small cell lung cancer
Results
Phase 1/2
This trial looked at taladegib (LY2940680) with carboplatin and etoposide chemotherapy for small cell lung cancer. It was for people whose cancer had spread beyond the lungs.
It was open for people to join between 2013 and 2014. The team analysed the results in 2018. There are links to more information in the ‘Summary of results’ section below.
Recruitment start: 1 May 2013
Recruitment end: 8 September 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Forster
Eli Lilly and Company Limited
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 18 March 2024
CRUK internal database number: 10666
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
